Eli Lilly looks beyond GLP-1s with a $3 billion cancer buy Apr 23, 2026 · Quartz Staff Eli Lilly announced it will acquire Kelonia Therapeutics for $3.25 billion upfront to expand its oncology and genetic medicines pipeline Read more »